Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure.

[1]  M. Kattan,et al.  In‐hospital red blood cell distribution width change in patients with heart failure , 2019, European journal of heart failure.

[2]  A. Mizuno,et al.  Prognostic Value of BNP Reduction During Hospitalization in Patients With Acute Heart Failure. , 2019, Journal of cardiac failure.

[3]  M. Packer.  Why Are Physicians So Confused about Acute Heart Failure? , 2019, The New England journal of medicine.

[4]  P. Ponikowski,et al.  Effects of Serelaxin in Patients with Acute Heart Failure. , 2019, The New England journal of medicine.

[5]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[6]  V. Harjola,et al.  Acute Heart Failure , 2018, Update in Intensive Care and Emergency Medicine.

[7]  Y. Shiraishi,et al.  9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries , 2018, Journal of the American Heart Association.

[8]  W. Tang,et al.  Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure , 2018, Open Heart.

[9]  C. Granger,et al.  Post-Myocardial Infarction Heart Failure. , 2018, JACC. Heart failure.

[10]  R. Matsukawa,et al.  Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.

[11]  P. Ponikowski,et al.  Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure , 2017, European journal of heart failure.

[12]  J. Butler,et al.  A simple score for early risk stratification in acute heart failure. , 2017, International journal of cardiology.

[13]  Hsien-Yen Chang,et al.  Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure , 2017, PloS one.

[14]  F. McAlister,et al.  Early Follow-Up After a Heart Failure ExacerbationCLINICAL PERSPECTIVE , 2016 .

[15]  S. Anker,et al.  Heart failure epidemiology and novel treatments in Japan: facts and numbers , 2016, ESC heart failure.

[16]  G. Filippatos,et al.  Reframing the association and significance of co‐morbidities in heart failure , 2016, European journal of heart failure.

[17]  Massimo Iacoviello,et al.  Predicting mortality in patients with acute heart failure: Role of risk scores. , 2015, World journal of cardiology.

[18]  H. Shimokawa,et al.  Heart failure as a general pandemic in Asia , 2015, European journal of heart failure.

[19]  A. Gavazzi,et al.  Prognostic scores in heart failure - Critical appraisal and practical use. , 2015, International journal of cardiology.

[20]  W. Shimizu,et al.  New scoring system (APACHE-HF) for predicting adverse outcomes in patients with acute heart failure: evaluation of the APACHE II and Modified APACHE II scoring systems. , 2014, Journal of cardiology.

[21]  Y. Pinto,et al.  A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score , 2013, Heart.

[22]  F. Oliva,et al.  Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score. , 2013, International journal of cardiology.

[23]  B. Massie,et al.  Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. , 2013, JACC. Heart failure.

[24]  S. Basu.  The neglected role of blood pressure in acute heart failure syndrome , 2011, Heart.

[25]  V. Hasselblad,et al.  Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. , 2010, Journal of the American College of Cardiology.

[26]  G. Felker,et al.  Red blood cell distribution width and 1‐year mortality in acute heart failure , 2010, European journal of heart failure.

[27]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[28]  S. Manzano-Fernández,et al.  Red blood cell distribution width predicts long‐term outcome regardless of anaemia status in acute heart failure patients , 2009, European journal of heart failure.

[29]  B. Ovbiagele,et al.  Elevated red blood cell distribution width predicts mortality in persons with known stroke , 2009, Journal of the Neurological Sciences.

[30]  C. O'connor,et al.  Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, American heart journal.

[31]  B. Davis,et al.  Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease , 2008, Circulation.

[32]  A. Cohen-Solal,et al.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. , 2007, JAMA.

[33]  Nancy M Albert,et al.  Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. , 2006, JAMA.

[34]  D. Mozaffarian,et al.  The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.

[35]  Peter C Austin,et al.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.

[36]  F. Gardner,et al.  Improved classification of anemias by MCV and RDW. , 1983, American journal of clinical pathology.

[37]  A. Mebazaa,et al.  AHEAD score--Long-term risk classification in acute heart failure. , 2016, International journal of cardiology.

[38]  A. Cohen-Solal,et al.  Prognostic markers of acute decompensated heart failure: the emerging roles of cardiac biomarkers and prognostic scores. , 2015, Archives of cardiovascular diseases.